COVID-19 with Hyperglycemia Among Iraqi Patients in Baghdad

Abstract

Background: The corona virus infects many organs of the body other than the respiratory system. It is necessary to highlight other infections caused by COVID-19 and therefore, the objective of our research is to study the relationship between the novel coronavirus and hyperglycemia, and its impact on some biochemical parameters in the serum of Iraqi patients. Material and Methods: The study, which took place in Abu Ghraib-Baghdad from September to December 2021. The findings of subjects who suffer from high blood sugar were selected from the tests that were conducted for many COVID-19 patients in our laboratory, and they were not suffering from this rise previously, and they are forty subjects (20 males and 20 females). The ages of all participants was ranged from 40 and 60 years. They were found to be infected with COVID-19 after a Real-time polymerase chain reaction test from nasopharyngeal swabs. Measured the body mass index, fasting plasma glucose, glycosylated hemoglobin, some positive acute phase reactants (C-reactive protein and D-dimer), and lactate dehydrogenase in the serum. Results: All patients studied had elevated fasting plasma glucose and glycosylated hemoglobin levels. C-reactive protein and D-dimer were also elevated but lactate dehydrogenase was high in 32.5% of the studied patients. The mean of body mass index was 28.73±4.51 kg/m2 (overweight). Conclusion: We concluded that COVID-19 caused hyperglycemia in some Iraqi patients at Baghdad, in addition to respiratory infections.